4//SEC Filing
REXAHN PHARMACEUTICALS, INC. 4
Accession 0001140361-16-058648
$IRDCIK 0001228627operating
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 9:20 PM ET
Size
5.0 KB
Accession
0001140361-16-058648
Insider Transaction Report
Form 4
Suzdak Peter David
Chief Executive Officer
Transactions
- Award
Common Stock
2016-03-18$0.32/sh+60,000$19,386→ 60,000 total
Footnotes (1)
- [F1]The price of $0.3231 per share represents a weighted average of purchase prices ranging from $0.3216 to $0.3244 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Documents
Issuer
REXAHN PHARMACEUTICALS, INC.
CIK 0001228627
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001228627
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 9:20 PM ET
- Size
- 5.0 KB